EP0288809A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Bifunctional proteins
Assignee: Hoechst AG
•
Filing: 1988-04-09
•
Granted: —
•
Expires: 2008-04-09
Abstract
Abstract Bifunctional proteins obtainable by genetic engineering from an interleukin-2 and a granulocyte-macrophage "colony stimulating" factor fraction have the biological activity of both components, but are distinguished by increased stability. These proteins are thus medicaments which are suitable for the treatment of malignant neoplasms.
Inventors
- 👤 Paul Dr. Habermann
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-23 19:45
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/62; A; A61; A61P; A61P35/00; C07; C07K; C07K14/00; C07K14/435; C07K14/52; C07K14/53; C07K14/535; C07K14/54; C07K14/55; A61K; A61K38/00; C07K2319/00; C07K2319/70; C07K2319/74; C07K2319/75
Claims Analysis
Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.
References Cited (Backward Citations)
EP0136489A1
Cited
EP0142268A1
Cited
EP0158198A1
Cited
WO1985004673A1
Cited
EP0163249A2
Cited
EP0183350A2
Cited
EP0194818A2
Cited
WO1987002060A1
Cited
EP0227938A2
Cited
EP0228018A2
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.